Cost of Goods Sold (Annual)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Select Medical Holdings Corporation (SEM) had Cost of Goods Sold of $4.55B for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$5.19B
Net Income	$214.04M
Cost of Goods Sold	$4.55B
Gross Profit	$633.64M
Operating Expenses	$4.92B
Operating Income	$268.31M
Non-Operating Income/Expense	$-93.55M
Pre-Tax Income	$174.77M
Normalized Pre-Tax Income	$174.77M
Income after Taxes	$129.99M
Income from Continuous Operations	$129.99M
Consolidated Net Income/Loss	$296.70M
Normalized Income after Taxes	$129.99M
EBIT	$268.31M
EBITDA	$475.17M
Weighted-Average Shares Outstanding (Basic)	124.61M
Weighted-Average Shares Outstanding (Diluted)	124.61M
Earnings per Share (EPS) (Basic)	$1.66
Earnings per Share (EPS) (Diluted)	$1.66
Balance Sheet Financials
Current Assets	$1.02B
Property, Plant, and Equipment	$872.18M
Long-Term Assets	$4.59B
Total Assets	$5.61B
Current Liabilities	$977.65M
Long-Term Debt	$1.69B
Long-Term Liabilities	$2.64B
Total Liabilities	$3.62B
Common Equity	$1.99B
Tangible Shareholders Equity	$-448.15M
Shareholders Equity	$1.99B
Common Shares Outstanding	128.96M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$517.86M
Cash Flow from Investing Activities	$-231.01M
Cash Flow from Financial Activities	$-311.17M
Beginning Cash	$84.01M
End Cash	$59.69M
Increase/Decrease in Cash	$-24.31M
Stock-Based Compensation	$100.67M
Common Stock Dividends Paid	$-64.62M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.04
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.46
Debt to Equity Ratio	0.87
Gross Margin	12.22%
Operating Margin	5.17%
EBIT Margin	5.17%
EBITDA Margin	9.16%
Pre-Tax Profit Margin	3.37%
Profit Margin	4.13%
Free Cash Flow	$299.95M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.93
Inventory Turnover	--
Receiveable Turnover	6.12
Days Sales in Receivables	59.67
Return on Equity	6.54%
Return on Tangible Equity	-29.01%
Return on Assets	2.32%
Return on Investments	3.53%
Book Value Per Share	$15.41
Free Cash Flow per Share	$2.41
Operating Cash Flow per Share	$4.16

Data from Zacks Investment Research, Inc.